Financiación
Investigador/a: Assunta Cirella
4 financiaciones - 1.047.728€
2021
-
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
euro 459.800,00
-
Desarrolo preclínico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 STING
euro 126.500,00
-
INTERLEUKIN-8 AND NEUTROPHIL EXTRACELLULAR TRAPS AS ACTIONABLE TARGET AND BIOMARKERS FOR CANCER IMMUNOTHERAPY
euro 213.555,00
2018
-
H2020-ITN Tumor Treg Targeting
euro 247.873,00